← Open Payments lookup

PHILIP LANDRY: Open Payments

NPI 1639218738 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$416 in 20 payments from 10 companies in 2025. Trend: 2023 $73 · 2024 $58 · 2025 $416

Food & beverage: $416
CompanyPaymentsAmount
ABBVIE INC.6$96
Takeda Pharmaceuticals U.S.A., Inc.3$69
Teva Pharmaceuticals USA, Inc.2$53
Corium, LLC2$41
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$35
HARMONY BIOSCIENCES LLC1$33
E.R. Squibb & Sons, L.L.C.2$32
Otsuka America Pharmaceutical, Inc.1$23
Alkermes, Inc.1$20
Astellas Pharma US Inc1$15

Products named: VRAYLAR, TRINTELLIX, Azstarys, CAPLYTA, WAKIX, COBENFY, UZEDY, AUSTEDO XR.

Industry payments across LA — which companies pay providers there.